Effect of Zinc Supplement on Children with Asthmatic Disease
Phase 2
- Conditions
- Asthmatic Patients.Asthma
- Registration Number
- IRCT201105316660N1
- Lead Sponsor
- Mazandaran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
age between 5-17 years old; asthma more than 1 year; FEV1 <80%.
Exclusion criteria: heart, kidney, liver and thyroid diseases; normal spirometry; recent pneumonia and sinusitis; intake of Vitamins or Trace elements.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical manifestation of asthma. Timepoint: 8 weeks. Method of measurement: observation.;Spirometry. Timepoint: 8 Weeks. Method of measurement: Spirometer.
- Secondary Outcome Measures
Name Time Method Eosinophil. Timepoint: 8 weeks. Method of measurement: laboratory test.;Total IgE. Timepoint: 8 Weeks. Method of measurement: Labratory Test.